BIO-Europe 2026: Global Biopharma Leaders to Meet in Cologne Amid Growing Confidence

Scheduled for November 9-11, 2026, BIO-Europe will host over 6,000 senior executives in Cologne, Germany. As the 32nd edition of this prestigious event, it arrives during a period of increasing confidence in biopharma dealmaking, despite ongoing financing hurdles. Claire Macht from Informa Connect highlights the event's role in fostering dialogue among industry leaders about scientific innovation and strategic shifts in biopharma.

Recent insights from the Biopharma C-Suite Agenda Survey suggest rising interest in partnerships and mergers. However, European biotech firms face challenges in funding breakthrough therapies due to evolving capital markets. Jeremy Levin and Edwin Moses emphasize the need for innovative funding solutions and regulatory pathway reforms in Europe to support biotech growth.

The conference will also explore how globally competitive biotech ecosystems can be built, using North Rhine-Westphalia as a model of success. Registration details can be accessed on the BIO-Europe website.